Working together to shape the endometrial cancer research agenda: The top ten unanswered research questions

Gynecologic Oncology

Volumn 143, Issue 2, 2016, Pages 287-293

  Wan, Y Louise ^a,b   Beverley Stevenson, Rachel ^b   Carlisle, Daloni ^b   Clarke, Sinead ^b   Edmondson, Richard J ^a,b   Glover, Steve ^b,c   Holland, Julie ^b   Hughes, Carol ^b   Kitchener, Henry C ^a,b   Kitson, Sarah ^a,b   Miles, Tracie ^b   Morley, Richard ^b,d   Morrison, Jo ^b   Nelson, Linsey ^a,b   Powell, Melanie ^b   Sadler, Laura ^b   Tomlinson, Anne ^b   Tylko Hill, Katharine ^b   Whitcombe, Jo ^b,c   Crosbie, Emma J ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b Womb Cancer Alliance Priority Setting Partnership Study Group   (United Kingdom)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^d National Institute for Health Research Evaluation Trials and Studies Coordinating Centre ^*  (United Kingdom)

Author keywords

Collaborative; Endometrial cancer; James Lind Alliance; Research priorities; Shared decision making

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RESEARCH; CANCER SURVIVOR; CAREGIVER; ENDOMETRIUM CANCER; FEMALE; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESEARCH PRIORITY; SHARED DECISION MAKING; ADOLESCENT; COOPERATION; ENDOMETRIAL NEOPLASMS; MEDICAL RESEARCH; MIDDLE AGED; MORTALITY; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOMEDICAL RESEARCH; CAREGIVERS; COOPERATIVE BEHAVIOR; ENDOMETRIAL NEOPLASMS; FEMALE; HEALTH PERSONNEL; HUMANS; MIDDLE AGED;

EID: 84994144899     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2016.08.333     Document Type: Article

References (27)

1. [1] Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D., Bray, F., GLOBOCAN 2012 v1.0, Cancer Incidence & Mortality Worldwide: IARC CancerBase No 11. 2013, 10.1002/ijc.29210 (Internet).
2. [2] Uterine Cancer Incidence Statistics|Cancer Research UK, Cancer Res. UK, http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/uterine-cancer/incidence#heading-Two, 2016.
3. [3] Howlader, N., Noone, A., Krapcho, M., Miller, D., Bishop, K., Altekruse, S., Kosary, C., Yu, M., Ruhl, J., Tatalovich, Z., Mariotto, A., Lewis, D., Chen, H., Feuer, E., Cronin, K., SEER Cancer Statistics Review, 1975–2013. http://seer.cancer.gov/csr/1975_2013/, 2013.
4. [4] Rahib, L., Smith, B.D., Aizenberg, R., Rosenzweig, A.B., Fleshman, J.M., Matrisian, L.M., Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 74 (2014), 2913–2921, 10.1158/0008-5472.CAN-14-0155.
5. [5] Smith, B.D., Smith, G.L., Hurria, A., Hortobagyi, G.N., Buchholz, T.A., Future of cancer incidence in the United States: burdens upon an aging, changing nation. J. Clin. Oncol. 27 (2009), 2758–2765, 10.1200/JCO.2008.20.8983.
6. [6] Uterine Cancer Mortality Statistics|Cancer Research UK, http://www.cancerresearchuk.org/health-professional/uterine-cancer-mortality-statistics#ref1, 2012 (accessed February 17, 2016).
7. [7] Carlisle, D., Womb cancer: the most common diagnosis you've never heard of, Guard. https://www.theguardian.com/lifeandstyle/2014/sep/21/womb-cancer-fourth-most-common-women, 2014.
8. [8] The Eve Appeal, Stigma around gynaecological cancers could be costing lives. https://www.eveappeal.org.uk/media/244345/gcam_-_final.pdf, 2015 (accessed June 5, 2016).
9. [9] NCRI Data Package 2012, “Spend by disease site”. National Cancer Research Institute at http://www.ncri.org.uk/includes/Publications/general/Data_package_12.xls (n.d.).
10. [10] Fiscal Year 2013: Funding by Cancer Type. http://fundedresearch.cancer.gov/nciportfolio/reports/fy13/, 2016.
11. [11] Chalmers, I., Glasziou, P., Avoidable waste in the production and reporting of research evidence. Lancet 374 (2009), 86–89, 10.1016/S0140-6736(09)60329-9.
12. [12] Tallon, D., Chard, J., Dieppe, P., Relation between agendas of the research community and the research consumer. Lancet 355 (2000), 2037–2040, 10.1016/S0140-6736(00)02351-5.
13. [13] Chalmers, I., Bracken, M.B., Djulbegovic, B., Garattini, S., Grant, J., Gülmezoglu, A.M., Howells, D.W., Ioannidis, J.P.A., Oliver, S., How to increase value and reduce waste when research priorities are set. Lancet 383 (2014), 156–165, 10.1016/S0140-6736(13)62229-1.
14. [14] JLA Guidebook|James Lind Alliance. (n.d.) http://www.jla.nihr.ac.uk/jla-guidebook/.
15. [15] The PSPs|James Lind Alliance, (n.d.) http://www.jla.nihr.ac.uk/priority-setting-partnerships/.
16. [16] Jones, J., Hunter, D., Consensus methods for medical and health services research. BMJ 311 (1995), 376–380 http://www.ncbi.nlm.nih.gov/pubmed/7640549 (accessed August 24, 2016).
17. [17] Howick, J., Chalmers, I., Glasziou, P., Greenhalgh, T., Heneghan, C., Liberati, A., Moschetti, I., Phillips, R., Thornton, H., Explanation of the 2011 Oxford Centre for Evidence-Based Medicine (OCEBM) levels of evidence (background document). http://www.cebm.net/index.aspx?o=5653, 2011.
18. [18] Shafir, E., Tversky, A., Thinking through uncertainty: nonconsequential reasoning and choice. Cogn. Psychol. 24 (1992), 449–474 http://www.ncbi.nlm.nih.gov/pubmed/1473331 (accessed August 25, 2016).
19. [19] Shafir, E., Simonson, I., Tversky, A., Reason-based choice. Cognition 49 (1993), 11–36 http://www.ncbi.nlm.nih.gov/pubmed/8287671 (accessed August 25, 2016).
20. [20] Parkin, D.M., Boyd, L., Walker, L.C., The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br. J. Cancer 105 (2011), S77–S81, 10.1038/bjc.2011.489.
21. [21] Hood, L., Friend, S.H., Predictive, personalized, preventive, participatory (P4) cancer medicine. Nat. Rev. Clin. Oncol. 8 (2011), 184–187, 10.1038/nrclinonc.2010.227.
22. [22] Genomics England, 100,000 Genomes Project. (n.d.) https://www.genomicsengland.co.uk/taking-part/intro/.
23. [23] Pashayan, N., Reisel, D., Widschwendter, M., Integration of genetic and epigenetic markers for risk stratification: opportunities and challenges. Perinat. Med. 13 (2016), 93–95, 10.2217/pme.15.53.
24. [24] Tannenbaum, C., Mayo, N., Women's health priorities and perceptions of care: a survey to identify opportunities for improving preventative health care delivery for older women. Age Ageing 32 (2003), 626–635 http://www.ncbi.nlm.nih.gov/pubmed/14600004 (accessed August 24, 2016).
25. [25] Janovsky, K., Health Policy and Systems Development: An Agenda for Research. 1996 (doi:WHO/SHS/NHP/96.1, Geneva).
26. [26] Bryant, J., Sanson-Fisher, R., Walsh, J., Stewart, J., Health research priority setting in selected high income countries: a narrative review of methods used and recommendations for future practice. Cost Eff. Resour. Alloc., 12, 2014, 23, 10.1186/1478-7547-12-23.
27. [27] Bray, F., Jemal, A., Torre, L.A., Forman, D., Vineis, P., Long-term realism and cost-effectiveness: primary prevention in combatting cancer and associated inequalities worldwide. J. Natl. Cancer Inst., 107, 2015, djv273, 10.1093/jnci/djv273.